Brookline, MA, United States of America

Ethan A Lerner


Average Co-Inventor Count = 2.9

ph-index = 8

Forward Citations = 397(Granted Patents)


Location History:

  • Brookline, MA (US) (1994 - 2000)
  • Newton, MA (US) (1998 - 2002)
  • Chestnut Hill, MA (US) (2014 - 2019)

Company Filing History:


Years Active: 1994-2019

Loading Chart...
12 patents (USPTO):Explore Patents

Title: **Ethan A. Lerner: Pioneering Innovations in Itch Treatment**

Introduction

Ethan A. Lerner, based in Brookline, MA, is an innovative inventor known for his groundbreaking work in the field of dermatological pharmacology. With a total of 12 patents to his name, he has made significant contributions to the prevention and treatment of itch through various therapeutic methods.

Latest Patents

Ethan's recent patents showcase his dedication to addressing the complex mechanisms behind itch. One notable invention is focused on the "Prevention and Treatment of Itch with an MRGPR Antagonist." This patent describes compositions and methods that utilize MRG receptor antagonists, such as a specific tripeptide, QWF, to effectively prevent and treat non-histamine mediated itch. Another essential patent involves "Prevention and Treatment of Itch with Cysteine Protease Inhibition." This work provides methods for utilizing a cysteine protease inhibitor directed to cathepsin S, targeting itch that is not associated with conditions like psoriasis and atopic dermatitis, confirming his innovative approach to itch management.

Career Highlights

Throughout his career, Ethan A. Lerner has collaborated with notable organizations such as The General Hospital Corporation and Bunsen Rush Laboratories, Inc. His experience in these esteemed institutions has allowed him to push the boundaries of research and development in therapeutics, particularly within his niche of dermatological treatments.

Collaborations

Ethan has worked alongside esteemed colleagues, including Michael R. Lerner and Osamu Moro. These collaborations have fostered a rich environment for innovation, enabling the exploration of new ideas and methodologies in treating chronic itch conditions.

Conclusion

Ethan A. Lerner's contributions to the field of itch treatment reflect his extensive research and innovative spirit. With 12 patents and a steadfast commitment to finding effective therapies, he continues to pave the way for advancements in dermatological health. His work underscores the importance of targeted treatments in improving patient quality of life and addressing unmet medical needs in the domain of itch management.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…